Skip to content

13F-HR filed by Sio Capital Management, LLC

Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-17, with 30 holding rows worth $127,277,000.

Accession
0001214659-15-001432
Filed
2015-02-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, 30 entries on the cover page, a total value of $127,277,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $127,277,000 with VALUE read as thousands by filing date, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
QUOTIENT LTDG73268107SHS1,212,850$21,831,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR259,500$11,836,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR210,371$8,991,000thousands by filing date
COVIDIEN PLCG2554F113SHS85,500$8,745,000thousands by filing date
ADAMIS PHARMACEUTICALS CORP00547W208COM NEW1,168,566$7,210,000thousands by filing date
ARATANA THERAPEUTICS INC03874P101COM325,420$5,799,000thousands by filing date
ALMOST FAMILY INC020409108COM195,807$5,669,000thousands by filing date
CAREFUSION CORP14170T101COM89,600$5,317,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM62,100$5,013,000thousands by filing date
AGILE THERAPEUTICS INC00847L100COM749,887$4,604,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM372,043$4,472,000thousands by filing date
Johnson & Johnson478160104COM40,000$4,183,000thousands by filing date
PFENEX INC717071104COM560,765$4,026,000thousands by filing date
BIOSCRIP INC09069N108COM554,621$3,877,000thousands by filing date
ADMA BIOLOGICS INC000899104COM245,930$2,747,000thousands by filing date
ORTHOFIX INTL N VN6748L102COM78,007$2,345,000thousands by filing date
FORWARD PHARMA A/S34986J105SPONSORED ADR108,915$2,269,000thousands by filing date
CONMED CORP COM207410101Stock50,100$2,252,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock53,600$2,168,000thousands by filing date
NANOSPHERE INC63009F105COM5,386,213$2,112,000thousands by filing date
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK184,720$1,860,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock172,581$1,722,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock102,700$1,627,000thousands by filing date
MERIT MED SYS INC COM589889104Stock93,072$1,613,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM121,900$1,198,000thousands by filing date
CTI BIOPHARMA CORP COM NEW12648L106Stock505,000$1,192,000thousands by filing date
REWALK ROBOTICS LTDM8216Q101SHS59,707$1,127,000thousands by filing date
CELSUS THERAPEUTICS PLC15119A202COM183,505$881,000thousands by filing date
HARVARD APPARATUS REGENER TE41690A106COM135,262$430,000thousands by filing date
ADVAXIS INC007624208COM NEW39,000$161,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-15-001432this filing2015-02-17acceptance time not in the bulk data set